A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer (Q36386030)

13 August 2017

1 reference

title

A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer (English)

1 reference

13 August 2017

Janusz A Jankowski

1

1 reference

13 August 2017

Ernest T Hawk

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Nature Reviews Gastroenterology & Hepatology

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

101-111

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep0412

13 August 2017

exact match

0 references

cites work

Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Diet, nutrition and the prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

The promise of genetically engineered mice for cancer prevention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Lessons from the withdrawal of rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Improving the evaluation of new cancer treatments: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Cancer pharmacogenetics: polymorphisms, pathways and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Cancer epidemiology in the last century and the next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

The advantages and disadvantages of adaptive designs for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Hempelian and Kuhnian approaches in the philosophy of medicine: the Semmelweis case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

Cancer prevention and the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

The critical role of risk-benefit assessments in cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Prospective study of serum selenium levels and incident esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Fruit, vegetables, dietary fiber, and risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Low-dose aspirin and incidence of colorectal tumors in a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Can animal models help us select specific compounds for cancer prevention trials?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Evaluating the efficiency of targeted designs for randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0412

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0412

1 reference

Dimensions Publication ID

13 August 2017

1042333716

0 references

1 reference